Development of Bacterial Beta-glucuronidase-specific Inhibitors to Reduce Chemo-induced Intestinal Toxicity and Prevent Tumorigenesis
博士 === 國立中山大學 === 生物醫學研究所 === 106 === Hepatic glucuronidation is a major route for detoxification. Drugs and carcinogens are conjugated with glucuronic acid to be inactive. However, the inactive glucuronides are reactivated back to active toxins by bacterial β-glucuronidase (βG) in the intestine, th...
Main Authors: | Kai-Wen Cheng, 鄭凱文 |
---|---|
Other Authors: | Tian-Lu Cheng |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/skc37g |
Similar Items
-
Development of bacteria-specific beta-glucuronidase inhibitor for the prevention of chemotherapy-induced diarrhea
by: Yei-Chung Huang, et al.
Published: (2012) -
Investigation of herbal extracts to inhibit intestinal beta-glucuronidase for cancer hemotherapy
by: Shih-Kai Chou, et al.
Published: (2014) -
Efficient Synthesis of Iminosugars as Bacterial β-Glucuronidase Inhibitors
by: Chia-Yu Chen, et al.
Published: (2019) -
Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity
by: Hsien-Ya Lin, et al.
Published: (2021-03-01) -
Discovery of Specific Inhibitors for Intestinal E. coli β-Glucuronidase through In Silico Virtual Screening
by: Ta-Chun Cheng, et al.
Published: (2015-01-01)